BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2017
View Archived Issues
Akebia Therapeutics obtains license to HIF-targeting products from Janssen
Read More
Mount Tam Biotechnologies advances its novel compound TAM-03 to treat a range of cancer types
Read More
Allergy Therapeutics announces CTA approval for phase I trial of house dust mite allergy vaccine
Read More
Sanofi offers overview of fourth quarter 2016
Read More
Mundipharma and Helsinn expand agreements for antiemetic drugs
Read More
Macrophage EP2/NF-kappaB pathway as a novel therapeutic target for intracranial aneurysms
Read More
Ionis Pharmaceuticals earns milestone from Bayer for advancing antisense drugs
Read More
Phase I study of Vaxart's norovirus tablet vaccine meets endpoints
Read More
FDA grants fast track designation to Axsome Therapeutics' AXS-05
Read More
Otsuka Pharmaceutical reviews milestones of fourth quarter 2016
Read More
Engineered plant cells allow protein delivery for tolerance induction for hemophilia treatment
Read More
TB Alliance describes novel compounds for tuberculosis
Read More
RCSI and Almac collaborate on treatment-resistant cancer
Read More
Armetheon receives advice from EMA on pivotal study of oral anticoagulant
Read More
Merck & Co. to stop phase II/III EPOCH study of verubecestat for lack of efficacy
Read More
Kenneth Rainin Foundation awards grants to support research into IBD
Read More
AMAG Pharmaceuticals and Endoceutics sign U.S. license agreement for Intrarosa
Read More
miR-124-3p, a potential therapeutic target and biomarker in major depressive disorder
Read More
Incyte and Agenus amend 2015 license, development and commercialization agreement
Read More
Amgen submits sBLA to FDA for Blincyto
Read More
Ardelyx's phase III trial of tenapanor meets primary endpoint
Read More
AbbVie files for Japanese approval of glecaprevir/pibrentasvir
Read More
CTHBP and IF1 as novel biomarkers of dermatomyositis
Read More
Gilead Sciences launches Vemlidy in Japan
Read More
NanoPass and IDRI to collaborate on Zika virus vaccine
Read More
